Jonathan Slawik
Homburg, SL, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
Journal: European journal of heart failure
Published: December 05, 2022
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial.
Journal: European journal of heart failure
Published: August 16, 2022
'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor.
Journal: ESC heart failure
Published: August 10, 2021
Timely and individualized heart failure management: need for implementation into the new guidelines.
Timely and individualized heart failure management: need for implementation into the new guidelines.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: March 30, 2021
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
Journal: The American journal of cardiology
Published: January 14, 2021
Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer.
Journal: ESC heart failure
Published: January 24, 2020
Optimization of Heart Failure Treatment by Heart Rate Reduction.
Journal: International journal of heart failure
Published: October 23, 2019
Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial.
Journal: European journal of heart failure
Published: July 08, 2019
Irregular pacing of ventricular cardiomyocytes induces pro-fibrotic signalling involving paracrine effects of transforming growth factor beta and connective tissue growth factor.
Journal: European journal of heart failure
Published: March 21, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026